Lubner David Charles 4

What Happened David Charles Lubner, a director of Dyne Therapeutics (DYN), reported a gift of 53,625 shares on April 24, 2026. The transaction is coded as a gift (G) on the Form 4; price per share is listed as $0.00 and the transaction generated no proceeds.

Key Details

• Transaction date: 2026-04-24; Form 4 filed: 2026-04-28 (timely filing).
• Transaction type/code: Gift (G).
• Shares transferred/disposed: 53,625; reported price: $0.00; reported proceeds: $0.
• Shares owned after transaction: not specified in the information provided on the Form 4.
• Filing accession: 0001193125-26-187601.
• No 10b5-1 plan, tax-withholding, or other footnotes were disclosed in the summary provided.

Context Gifts of shares are personal transfers and do not necessarily reflect an insider’s view of the company’s prospects; they can be for estate planning, charitable donations, or family transfers. Because this was a gift (not a sale or purchase), it does not provide the same market-signaling information that a purchase would.